Maturity onset diabetes of the young: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 17: Line 17:


{{SK}} MODY;
{{SK}} MODY;
==Signs, symptoms and differential diagnosis==
There are two general types of clinical presentation. Some forms of MODY produce significant [[hyperglycemia]] and the typical signs and symptoms of diabetes: increased thirst and urination (polydipsia and polyuria). In contrast, however, many people with MODY have no signs or symptoms and are diagnosed by either accident, when a high glucose is discovered during testing for other reasons, or screening of relatives of a person discovered to have diabetes. Discovery of mild hyperglycemia during a routine [[glucose tolerance test]] for [[pregnancy]] is particularly characteristic.
MODY cases may make up as many as 5% of presumed type 1 and type 2 diabetes cases in a large clinic population. While the goals of diabetes management are the same no matter what type, there are two primary advantages of confirming a diagnosis of MODY. Firstly, insulin may not be necessary and it may be possible to switch a person from insulin injections to oral agents without loss of [[Diabetes management#Glycemic control|glycemic control]]. Secondly, it may prompt screening of relatives and so help identify other cases in family members.
As it occurs infrequently, many cases of MODY are initially assumed to be more common forms of diabetes: type 1 if the patient is young and not overweight,  type 2 if the patient is overweight, or [[gestational diabetes]] if the patient is pregnant. Standard diabetes treatments (insulin for type 1 and gestational diabetes, and oral hypoglycemic agents for type 2) are often initiated before the doctor suspects a more unusual form of diabetes. In some forms of MODY, standard treatment is appropriate, though exceptions occur. For example, in MODY2, oral agents are relatively ineffective and insulin is unnecessary, while in MODY1 and MODY3, insulin may be more effective than drugs to increase insulin sensitivity. [[Sulfonylurea]]s are effective in the K<sub>ATP</sub> channel forms of neonatal-onset diabetes.
The following characteristics suggest the possibility of a diagnosis of MODY in hyperglycemic and diabetic patients:
* Mild to moderate hyperglycemia (typically 130-250 mg/dl, or 7-14 mM) discovered before 30 years of age.
* A first degree relative with a similar degree of diabetes.
* Absence of positive antibodies or other [[autoimmunity]] (e.g., [[thyroiditis]]) in patient and family.
* Persistence of a low insulin requirement (e.g., less than 0.5 u/kg/day) past the usual "honeymoon" period.
* Absence of obesity (though obese people can get MODY), or other problems associated with type 2 diabetes or [[metabolic syndrome]] (e.g. [[hypertension]], [[hyperlipidemia]], [[polycystic ovary syndrome]]).
* Cystic [[kidney]] disease in patient or close relatives.
*Non-transient neonatal diabetes, or apparent [[type 1 diabetes mellitus|type 1 diabetes]] with onset before 6 months of age.
The diagnosis of MODY is confirmed by specific [[gene]] testing, now available through several commercial [http://www.genetests.org/servlet/access?id=8888892&key=Ocb32xYXEzdQY&fcn=y&fw=iHXb&filename=/ laboratories].


==Management==
==Management==

Revision as of 01:48, 20 September 2012

Maturity onset diabetes of the young
OMIM 606391
DiseasesDB 8330
MeSH D003924

Maturity onset diabetes of the young Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Maturity onset diabetes of the young from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Maturity onset diabetes of the young On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Maturity onset diabetes of the young

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Maturity onset diabetes of the young

CDC on Maturity onset diabetes of the young

Maturity onset diabetes of the young in the news

Blogs on Maturity onset diabetes of the young

Directions to Hospitals Treating Maturity onset diabetes of the young

Risk calculators and risk factors for Maturity onset diabetes of the young

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: MODY;

Management

Unfortunately, chronic hyperglycemia of any cause can eventually cause blood vessel damage and the microvascular complications of diabetes. The principal treatment goals for people with MODY — keeping the blood sugars as close to normal as possible ("good glycemic control"), while minimizing other vascular risk factors — are the same for all known forms of diabetes.

Tools available for management are also those available for all forms of diabetes: blood testing, changes in diet, physical exercise, oral hypoglycemic agents, and insulin injections. In many cases these goals can be achieved more easily with MODY than with ordinary types 1 and 2 diabetes. Some people with MODY may require insulin injections to achieve the same glycemic control that another person may attain with careful eating or an oral medication.

When oral hypoglycemic agents are used in MODY, the sulfonylureas remain the oral medication of first resort. Patients with MODY less often suffer from obesity and insulin resistance than those with ordinary type 2 diabetes (for whom insulin sensitizers like metformin or the thiazolidinediones are often preferred over the sulfonylureas).

References

Further reading

  • Fajans SS (1990). "Scope and heterogeneous nature of MODY". Diabetes Care. 13 (1): 49–64. doi:10.2337/diacare.13.1.49. PMID 2404717. (For historical perspective, this review covers the concept just before the nature of the first of the specific molecular defects was discovered. It illustrates the significant change in the disease(s) referred to as MODY before and after 1990.)
  • Dean L and McEntyre J, 2004. The Genetic Landscape of Diabetes. Bethesda:NCBI, 2004. This is an entire online textbook on the complex genetics of the forms of diabetes. The chapter on MODY provides an up-to-date and concise overview of the molecular defects. Little expansion of clinical knowledge of the 6 types since 2001 has occurred.

External links

it:Maturity onset diabetes of the young

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Maturity_onset_diabetes_of_the_young&oldid=744967"